S. Gaine (Dublin, Ireland), S. Ulrich (Zurich, Switzerland)
Iron deficiency in idiopathic pulmonary arterial hypertension
C. J. Rhodes, L. S. Howard, M. Busbridge, D. Ashby, E. Kondili, J. S. R. Gibbs, M. R. Wilkins, J. Wharton (United Kingdom)
|   |
Novel biomarkers in idiopathic pulmonary arterial hypertension
C. J. Rhodes, J. Wharton, L. S. Howard, J. S. R. Gibbs, M. R. Wilkins (United Kingdom)
| |
Identification of novel diagnostic biomarkers of chronic thromboembolic pulmonary hypertension using MALDI-TOF-MS
T. Yano, K. Sogawa, M. Satoh, H. Umemura, T. Sugiura, S. Kitazono, K. Yamauchi, S. Sakao, Y. Kasahara, N. Tanabe, K. Tatsumi, F. Nomura (Japan)
| |
Circulating angiopoietins in idiopathic pulmonary arterial hypertension
N. Nickel, P. Kümpers, A. Lukasz, H. Golpon, V. Westerkamp, K. Olsson, S. David, M. Hoeper (Germany)
| |
CXCL12 as a potential disease marker for pulmonary hypertension
B. McCullagh, C. Costello, S. Gaine, P. McLoughlin (Dublin, Ireland)
| |
Pathophysiology of hypoxemia in IPAH – On the crossroads of respiratory and circulatory dysfunction
M. Szturmowicz, A. Kacprzak, M. Franczuk, A. Fijalkowska, M. Kurzyna, J. Kober, S. Wesolowski, A. Torbicki (Warsaw, Poland)
| |
Increase in right ventricular oxygen consumption during exercise in pulmonary hypertension critically depends on myocardial perfusion
Y. Y. Wong, P. Raijmakers, M. Lubberink, P. Knaapen, W. van der Laarse, N. Westerhof, A. Vonk-Noordegraaf (Amsterdam, Netherlands)
| |
Analysis of mortality risk factors in a population with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
M. López-Meseguer, C. Berastegui, E. Domingo, V. Monforte, R. Aguilar, C. Bravo, A. Román (Barcelona, Spain)
| |
Pulmonary hypertension of groups I and IV in 168 adult patients
C. Berastegui, M. López-Meseguer, R. Aguilar, C. Bravo, V. Monforte, E. Domingo, A. Román (Barcelona, Spain)
| |
Abnormal mean pulmonary artery pressure on mild exercise in subjects aged ≥ 50 years: A critical update
K. Whyte, H. Philippe, S. Hoette, X. Jais, O. Sitbon, G. Simonneau, M. Humbert, D. Chemla (Clamart, Bicetre, France)
| |
PAH etiologies at diagnosis in a large reference centre in Brazil
B. Dias, C. Jardim, C. Fernandes, S. Hoette, L. Kato, A. Hovnanian, R. Souza (Sao Paulo, Brazil)
| |
CompERA-XL: International, prospective registry for the documentation of first-line and maintenance therapy in patients with pulmonary hypertension
D. Pittrow, D. Vizza, A. Vonk-Noordegraaf, C. Opitz, D. Huscher, H. A. Ghofrani, J. L. Vachiery, S. Gaine, O. Distler, S. Gibbs, M. Hoeper (Dresden, Berlin, Hannover, Giessen, Germany; Amsterdam, Netherlands; Brussels, Belgium; Dublin, Ireland; , Switzerland; London, United Kingdom; Rome, Italy)
| |
Predictor markers of early pulmonary hypertension in patients with collagen diseases
I. Tiglea, M. Popescu, A. Dumitrascu, D. Marta, E. Iordachita, E. Moldoveanu, C. Tanaseanu (Bucharest, Romania)
| |
Refining definitions of time to clinical worsening in connective tissue disease-associated pulmonary arterial hypertension
R. Zamanian, L. Chung, L. Parsons, D. Miller, Z. Safdar, M. McGoon, P. Hassoun, M. Nicolls, A. Frost (San Francisco, Houston, Rochester, Baltimore, United States Of America)
| |
Single centre experience of connective tissue disease (CTD) associated pulmonary arterial hypertension (PAH): Impact of a supra-regional screening programme
J. Hurdman, R. Condliffe, C. A. Elliot, R. Kilding, M. Akil, C. Billings, I. Armstrong, N. Hamilton, D. G. Kiely (Sheffield, United Kingdom)
| |
Application of a formula to predict mean pulmonary artery pressures in patients with connective tissue disease
B. Schreiber, C. Valerio, C. Handler, G. Keir, A. Wells, C. Denton, G. Coghlan (London, United Kingdom)
| |
Pulmonary hypertension in patients with neurofibromatosis type I
D. Montani, F. Coulet, B. Girerd, M. Eyries, H. Mal, R. Borie, C. Dromer, C. Marquette, G. Zalcman, C. O‘Connell, D. O‘Callaghan, L. Savale, X. Jaïs, O. Sitbon, G. Simonneau, M. Humbert, F. Soubrier (Clamart, Paris, France)
| |
Pulmonary and systemic vascular dysfunction in apparently healthy adolescents conceived by assisted reproductive technologies
C. Sartori, S. Rimoldi, E. Rexhaj, M. Germond, P. Nicod, Y. Allemann, U. Scherrer (Lausanne-CHUV, Bern, Lausanne, Switzerland)
| |